SEC Tracker
Get the app

Anavex Life Sciences AVXL

The Company entered into a purchase agreement with Lincoln Park Capital Fund, LLC

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 10.1
Material contract
Exhibit 10.2
Material contract
  • Signs a material agreement (1.01)
  • Sells unregistered shares (3.02)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Anavex Life Sciences files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. ImmunityBio IBRX public float $690M, Jun 30, 2025
  2. Immunome IMNM public float $729M, Jun 30, 2025
  3. Pacira BioSciences PCRX public float $758M, Jun 30, 2025
  4. Phibro Animal Health PAHC public float $764M, Dec 31, 2025
  5. uniQure QURE public float $765M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.